martindale.com
Legal Library
|
Biosimilar Bill Reported From Senate Committee by Daniel A. Kracov
Arthur N. Levine
William W. Vodra
Donald Beers
Gregory Levine
Arnold & Porter LLP
Washington Office
| |
|
July 20, 2009
Previously published on July 2007
Bipartisan legislation (S. 1695 (the Biologics Price Competition and Innovation Act)) that would create a mechanism for FDA approval of "biosimilar" (also referred to as "follow-on," "comparable," or "biogeneric") biologic products was reported out of the Senate Health, Education, Labor and Pensions (HELP) Committee on June 27, 2007. www.arnoldporter.com
|
The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
Practice Area Resource Centers
|
|
RSS | Blog | Advertising Opportunities | Site Map | Contact Us